New app could help children with diabetes avoid dangerous blood sugar swings

NCT ID NCT07470905

Completed Disease control Sponsor: Regency Hospital Kanpur Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested DiaBuddy, a mobile app designed to help children with type 1 diabetes and their families make better decisions about insulin dosing and managing sick days. Twenty-five children aged 5 to 18 used the app for three months. The study found that the app's recommendations matched those of a specialist doctor and that using it was linked to improved blood sugar control and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DiaBuddy mobile app (decision-support tool)
What this could lead to: If successful, this app could help children with type 1 diabetes and their families make safer insulin dosing and sick-day decisions at home, potentially improving blood sugar control and quality of life.
What could go wrong: This is a small pilot study with only 25 children, no control group, and short follow-up. The app's benefits may not hold up in larger, longer trials or in different settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES (T1D) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 1 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TYPE 1 DIABETES (T1D)

Contacts and locations

Locations

Regency Hospital

Kanpur, Uttar Pradesh, 208001, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.